ERBB2 and breast cancer: Increased glutamine metabolic activity has been observed in HER2-positive breast cancer tissue compared with other subtypes of breast cancer, through upregulation of glutamine metabolic proteins including glutaminase 1 (GLS1) and glutamate dehydrogenase (GDH) [39, 40].